Dr. Alberts is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st Street SW
Rochester, MN 55905- Is this information wrong?
Summary
- Steven R. Alberts, M.D., is a professor of oncology in the College of Medicine, Mayo Clinic, and a consultant in the Division of Medical Oncology. He has served as the chair of the Division of Medical Oncology since 2012 and has been interim chair of the Department of Oncology since 2019. He is also the Deputy Director for Clinical Research in the Mayo Clinic Cancer Center. External to Mayo Clinic Dr. Alberts serves as a member of the Board of Directors and the Board of Trustees for the Alliance.
Dr. Alberts has a clinical focus in gastrointestinal cancers and a specific interest in liver-based cancers and in pancreatic cancer.
Dr. Alberts has a long-standing research career that predates his appointment in medical oncology. He has a master's in public health and has worked as an epidemiologist with the Indian Health Service and the Centers for Disease Control and Prevention. In this former position, Dr. Alberts participated in studies of cancer in the Alaska Native population.
Dr. Alberts previously served as the chair of the GI Committee for the North Central Cancer Treatment Group. He also served as a member of the National Cancer Institute-sponsored Gastrointestinal Intergroup GI Steering Committee, Pancreas Cancer Task Force, and Colon Cancer Task Force to help coordinate clinical trials through the national cooperative groups.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1993 - 1997- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1990 - 1993
University of Washington School of MedicineClass of 1990
Certifications & Licensure
WI State Medical License 2023 - 2025
MN State Medical License 1991 - 2024- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma Start of enrollment: 1994 Jul 01
- Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer Start of enrollment: 1998 Mar 01
- Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer Start of enrollment: 1999 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials.Claire Gallois, Qian Shi, Levi D Pederson, Thierry André, Timothy J Iveson, Alberto F Sobrero, Steven Alberts, Aimery de Gramont, Jeffrey A Meyerhardt, Thomas George, ...> ;Journal of Clinical Oncology. 2024 Mar 28
- Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patients.Hanla A Park, Dominic Edelmann, Federico Canzian, Petra Seibold, Tabitha A Harrison, Xinwei Hua, Qian Shi, Allison Silverman, Axel Benner, Angelica Macauda, Martin Sch...> ;International Journal of Cancer. 2023 Nov 1
- 1 citationsBevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Coope...Bruce J Giantonio, Paul J Catalano, Neal J Meropol, Peter J O'Dwyer, Edith P Mitchell, Steven R Alberts, Michael A Schwartz, Al B Benson 3rd> ;Journal of Clinical Oncology. 2023 Jul 20
- Join now to see all
Journal Articles
- MiR-139-5p as a Novel Serum Biomarker for Recurrence and Metastasis in Colorectal CancerFrank A Sinicrope, Steven R Alberts, Ajay Goel, Nature
Press Mentions
Sharing Mayo Clinic: Georgia Man with Neuroendocrine Cancer Gains Quality of Life Thanks to New Nuclear Med TherapyApril 17th, 2022- Georgia Man with Neuroendocrine Cancer Gains Quality of Life Thanks to New Nuclear Med TherapyApril 14th, 2022
Therapeutic Advancements Changing Liver Cancer ParadigmSeptember 25th, 2017- Join now to see all
Grant Support
- NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1.National Cancer Institute.2019–2025
- Mayo Clinic Hepatobiliary SPORENational Cancer Institute2018–2023
- Minnesota Cancer Clinical Trials Network Regional Cancer Clinical Trials Funding OpportunityState of Minnesota2018–2020
- Clinical ResearchNational Cancer Institute2009–2012
- Core--Protocol Review And Monitoring SystemNational Cancer Institute2004–2008
- Phase II Trial Of Gemcitabine And DocetaxelNational Center For Research Resources2004
- BAY 12 9566 In Combination W/ Etoposide &Carboplatin In Cancer PatientsNational Center For Research Resources1999–2002
- Phase 2 Clinical Trial Of An Antiandrogen &A 5-AlphaDivision Of Cancer Prevention And Control1999
Professional Memberships
- Member
Hospital Affiliations
Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
